Please read our December eNews here
Click here to view the November edition of The Meeting Place
Welcome to the Autumn edition of BioBrief, our quarterly newsletter providing essential updates and analysis for those working in the life sciences sector.
In this edition you will find:
> A videocast on the recent decision of the Patents Court to uphold the validity of an important Astellas patent protecting their blockbuster product Mirabegron
> An article on how the UK is moving into the fast lane for biosimilar regulatory approvals
> An article outlining the new UK immigration routes in 2022
> Our newly developed SCC toolkit which will help you understand whether your…
AMSBIO has published an informative handbook for scientists who need to preserve or archive organoids in a research lab.
The handbook brings together published paper citations, quotes and data from leading international research groups who are using the CELLBANKER® range of products to cryopreserve their organoids simply and safely. In addition, the handbook includes best practice protocols plus information making it easier to understand the process of freezing organoids and to choose the optimum cryopreservation media for your application.
Proven capable of recreating aspects of organ…
Arecor Therapeutics plc
(“Arecor” or the “Group”)
ARECOR TO COMMENCE SECOND CLINICAL TRIAL WITH AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN CANDIDATE FOR TYPE 2 DIABETES
Clinical Trial Application approved
EU Phase I clinical trial expected to commence in December 2022
Cambridge, UK, 22 November 2022: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, today announces the BASG (Bundesamt für Sicherheit im Gesundheitswesen) clearance of the Group’s Clinical Trial Application (CTA) for AT278, an ultra-rapid acting,…
The granted patents further strengthen the Group’s extensive patent portfolio protecting its proprietary Arestat™ technology and diabetes product portfolio
Cambridge, UK, 22 November 2022: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical group advancing today’s therapies to enable healthier lives, is pleased to announce that the Japan Patent Office has granted a patent (JP7145849) protecting novel formulations of the Group’s proprietary insulin products, AT247 and AT278. The same patent has also been granted in South Korea.
Dr Jan Jezek, Chief Scientific Officer at Arecor, commented…
Newly built Research & Development (R&D) space is available at the Peterborough Research & Innovation Centre on Bishops Road, PE1 5BW.
The Research & Innovation Centre is set to provide a hub for science and technology businesses in Peterborough. Due for completion by the end of 2022, the building will be located adjacent to the newly opened ARU Peterborough campus. The building will seek to strengthen links between academia and industry, establish skills and learning in the very heart of the city, and provide a platform for an innovation eco-system with a university at…
In May 2022, we were honored to announce our collaboration with the Future of Work Institute (FOWI) to enhance our Employer of Choice webinar series to provide our members with real world insights, guidance, and best practices on becoming employers of choice to attract and develop their best team.
Fast forward five months and we have learnt how to; become a destination workplace, support our employees and colleagues through wellbeing strategies, overcome the challenges around hybrid working and finally, to become a great storyteller.
It has been a pleasure to work with expert facilitators,…
Domainex Ltd., a leading provider of integrated drug discovery services, is pleased to announce that it has made a number of strategic internal promotions to strengthen its Executive and Management teams. This expansion marks a period of ongoing growth for Domainex, and the newly bolstered teams will be pivotal in driving further development of the company.
Dr Natalie Winfield and Dr Catherine Stace immediately join the Executive Team, with Natalie taking on the position of Executive Director of Commercial Operations and Catherine the position of Executive Director of Business Development…